Literature DB >> 27748960

BRF1 mutations in a family with growth failure, markedly delayed bone age, and central nervous system anomalies.

Y H Jee1, N Sowada2, T C Markello3, I Rezvani4, G Borck2, J Baron1.   

Abstract

Linear growth failure can be caused by many different genetic abnormalities. In many cases, the genetic defect affects not only the growth plate, causing short stature but also other organs/tissues causing additional clinical abnormalities. A 10-year old boy was evaluated for impaired postnatal linear growth (height 113.3 cm, -4.6 SDS), a bone age that was delayed by 5 years, dysmorphic facies, cognitive impairment, and central nervous system anomalies. His younger brother, presented only with growth failure at 10 months of age. Exome sequencing identified compound heterozygous variants in the gene encoding RNA polymerase III transcription initiation factor 90 kDa subunit (BRF1) in both affected siblings: a missense mutation (c.875 C > G:p.P292R) and a frameshift mutation (c.551delG:p.C184Sfs). The frameshift mutation is expected to lead to nonsense-mediated mRNA decay (NMD) and/or to protein truncation. Expression of BRF1 with the P292R missense mutation failed to rescue yeast lacking BRF1. The findings confirm a previous report showing that biallelic mutations in BRF1 cause cerebellar-facial-dental syndrome. Our findings also help define the growth phenotype, indicating that the linear growth failure can become clinically evident before the neurological abnormalities and that a severely delayed bone age may serve as a diagnostic clue. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  BRF1; delayed bone age; exome sequencing; neurologic syndrome; severe short stature

Mesh:

Substances:

Year:  2016        PMID: 27748960      PMCID: PMC5389939          DOI: 10.1111/cge.12887

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  25 in total

Review 1.  Idiopathic short stature: definition, epidemiology, and diagnostic evaluation.

Authors:  J M Wit; P E Clayton; A D Rogol; M O Savage; P H Saenger; P Cohen
Journal:  Growth Horm IGF Res       Date:  2008-01-07       Impact factor: 2.372

2.  Mapping the protein interaction network for TFIIB-related factor Brf1 in the RNA polymerase III preinitiation complex.

Authors:  Seok-Kooi Khoo; Chih-Chien Wu; Yu-Chun Lin; Jin-Cheng Lee; Hung-Ta Chen
Journal:  Mol Cell Biol       Date:  2013-11-25       Impact factor: 4.272

3.  Analysis of DNA sequence variants detected by high-throughput sequencing.

Authors:  David R Adams; Murat Sincan; Karin Fuentes Fajardo; James C Mullikin; Tyler M Pierson; Camilo Toro; Cornelius F Boerkoel; Cynthia J Tifft; William A Gahl; Tom C Markello
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

Review 4.  MicroRNA regulation of neural stem cells and neurogenesis.

Authors:  Yanhong Shi; Xinyu Zhao; Jenny Hsieh; Hynek Wichterle; Soren Impey; Sourav Banerjee; Pierre Neveu; Kenneth S Kosik
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

5.  Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome is caused by a POC1A mutation.

Authors:  Ofer Sarig; Sagi Nahum; Debora Rapaport; Akemi Ishida-Yamamoto; Dana Fuchs-Telem; Li Qiaoli; Ksenya Cohen-Katsenelson; Ronen Spiegel; Janna Nousbeck; Shirli Israeli; Zvi-Uri Borochowitz; Gilly Padalon-Brauch; Jouni Uitto; Mia Horowitz; Stavit Shalev; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2012-07-26       Impact factor: 11.025

6.  The Biology of Stature.

Authors:  Youn Hee Jee; Jeffrey Baron
Journal:  J Pediatr       Date:  2016-03-26       Impact factor: 4.406

7.  Pol II and its associated epigenetic marks are present at Pol III-transcribed noncoding RNA genes.

Authors:  Artem Barski; Iouri Chepelev; Dritan Liko; Suresh Cuddapah; Alastair B Fleming; Joanna Birch; Kairong Cui; Robert J White; Keji Zhao
Journal:  Nat Struct Mol Biol       Date:  2010-04-25       Impact factor: 15.369

8.  BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies.

Authors:  Guntram Borck; Friederike Hög; Maria Lisa Dentici; Perciliz L Tan; Nadine Sowada; Ana Medeira; Lucie Gueneau; Holger Thiele; Maria Kousi; Francesca Lepri; Larissa Wenzeck; Ian Blumenthal; Antonio Radicioni; Tito Livio Schwarzenberg; Barbara Mandriani; Rita Fischetto; Deborah J Morris-Rosendahl; Janine Altmüller; Alexandre Reymond; Peter Nürnberg; Giuseppe Merla; Bruno Dallapiccola; Nicholas Katsanis; Patrick Cramer; Christian Kubisch
Journal:  Genome Res       Date:  2015-01-05       Impact factor: 9.043

9.  Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors.

Authors:  Andrew J Oler; Ravi K Alla; Douglas N Roberts; Alexander Wong; Peter C Hollenhorst; Katherine J Chandler; Patrick A Cassiday; Cassie A Nelson; Curt H Hagedorn; Barbara J Graves; Bradley R Cairns
Journal:  Nat Struct Mol Biol       Date:  2010-04-25       Impact factor: 15.369

10.  Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III.

Authors:  Isabelle Thiffault; Nicole I Wolf; Diane Forget; Kether Guerrero; Luan T Tran; Karine Choquet; Mathieu Lavallée-Adam; Christian Poitras; Bernard Brais; Grace Yoon; Laszlo Sztriha; Richard I Webster; Dagmar Timmann; Bart P van de Warrenburg; Jürgen Seeger; Alíz Zimmermann; Adrienn Máté; Cyril Goizet; Eva Fung; Marjo S van der Knaap; Sébastien Fribourg; Adeline Vanderver; Cas Simons; Ryan J Taft; John R Yates; Benoit Coulombe; Geneviève Bernard
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

View more
  9 in total

Review 1.  New developments in the genetic diagnosis of short stature.

Authors:  Youn Hee Jee; Jeffrey Baron; Ola Nilsson
Journal:  Curr Opin Pediatr       Date:  2018-08       Impact factor: 2.856

2.  MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass.

Authors:  Ellen Phillips; Naseer Ahmad; Li Sun; James Iben; Christopher J Walkey; Aleksandra Rusin; Tony Yuen; Clifford J Rosen; Ian M Willis; Mone Zaidi; Deborah L Johnson
Journal:  Elife       Date:  2022-05-25       Impact factor: 8.713

3.  Evidence That the Etiology of Congenital Hypopituitarism Has a Major Genetic Component but Is Infrequently Monogenic.

Authors:  Youn Hee Jee; Mariam Gangat; Olga Yeliosof; Adrian G Temnycky; Selena Vanapruks; Philip Whalen; Evgenia Gourgari; Cortney Bleach; Christine H Yu; Ian Marshall; Jack A Yanovski; Kathleen Link; Svetlana Ten; Jeffrey Baron; Sally Radovick
Journal:  Front Genet       Date:  2021-08-11       Impact factor: 4.599

4.  QRICH1 mutations cause a chondrodysplasia with developmental delay.

Authors:  Julian C Lui; Youn Hee Jee; Audrey Lee; Shanna Yue; Jacob Wagner; Deirdre E Donnelly; Karen S Vogt; Jeffrey Baron
Journal:  Clin Genet       Date:  2018-10-26       Impact factor: 4.438

Review 5.  Diagnostic Approach to Cerebellar Hypoplasia.

Authors:  Andrea Accogli; Nassima Addour-Boudrahem; Myriam Srour
Journal:  Cerebellum       Date:  2021-02-03       Impact factor: 3.847

Review 6.  RNA polymerase III transcription as a disease factor.

Authors:  Meghdad Yeganeh; Nouria Hernandez
Journal:  Genes Dev       Date:  2020-07-01       Impact factor: 11.361

7.  Maf1 and Repression of RNA Polymerase III-Mediated Transcription Drive Adipocyte Differentiation.

Authors:  Chun-Yuan Chen; Rainer B Lanz; Christopher J Walkey; Wen-Hsuan Chang; Wange Lu; Deborah L Johnson
Journal:  Cell Rep       Date:  2018-08-14       Impact factor: 9.423

8.  Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200.

Authors:  Karine Choquet; Diane Forget; Elisabeth Meloche; Marie-Josée Dicaire; Geneviève Bernard; Adeline Vanderver; Raphael Schiffmann; Marc R Fabian; Martin Teichmann; Benoit Coulombe; Bernard Brais; Claudia L Kleinman
Journal:  J Biol Chem       Date:  2019-03-21       Impact factor: 5.157

9.  Extracellular Vesicle Proteome of Breast Cancer Patients with and Without Cognitive Impairment Following Anthracycline-based Chemotherapy: An Exploratory Study.

Authors:  Yong Qin Koh; Ding Quan Ng; Chiu Chin Ng; Adrian Boey; Meng Wei; Siu Kwan Sze; Han Kiat Ho; Munjal Acharya; Charles L Limoli; Alexandre Chan
Journal:  Biomark Insights       Date:  2021-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.